Multicenter, Prospective, Randomized Study Investigating the Efficacy and Safety of a Reduced Immunosuppressive Therapy With Tacrolimus Once Daily in Comparison to Standard Triple Immunosuppression in Senior Renal Transplant Recipients
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2017
At a glance
- Drugs Tacrolimus (Primary) ; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms REDUCE
- 08 Aug 2017 Planned initiation date changed from 1 Feb 2017 to 1 Dec 2017.
- 11 Aug 2016 Planned initiation date changed from 1 Jun 2015 to 1 Feb 2017.
- 08 Jun 2015 New trial record